|

Livmarli Oral Product Clinical Trials

1 actively recruiting trial

Also known as: Maralixibat

Pipeline

Phase 4: 1

Top Sponsors

  • Mirum Pharmaceuticals, Inc.1

Indications

  • Liver Disease1
  • Alagille Syndrome1
  • Heart Disease1

Other1 trial

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.